Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps

    Screening for open angle glaucoma: a systematic review of cost-effectiveness studies

    Methodological quality of the review: Low confidence

    Author: Hernández R, Rabindranath K, Fraser C, Vale L, Blanco AA, Burr JM; OAG Screening Project Group

    Geographical coverage: United States of America (USA), Canada, United Kingdom (UK)

    Sector: Glaucoma

    Sub-sector: Open angle glaucoma

    Equity focus: Studies in adult population

    Review type: Other review

    Quantitative synthesis method: Narrative synthesis

    Qualitative synthesis method: Not applicable

    Background: Population screening for open angle glaucoma (OAG) could be considered as an intervention to reduce blindness by identifying individuals at an earlier stage of the disease. Due to limited healthcare resources, it is important to assess the cost-effectiveness of screening for OAG.

    Objectives:  To systematically review current evidence on the cost-effectiveness of screening strategies for open angle glaucoma.

    Main findings: Only four studies were found to be eligible in this review, with the most recent published in 1997. All four studies assessed the cost-effectiveness of screening for primary OAG. One study each was conducted in Canada and the USA, and two studies were from the UK.

    Authors note that the screening tests and treatments reported in these studies are now not considered to be best practice. In addition, authors stated that it was not possible to reinterpret the results of the studies in terms of a common outcome measure as there was no sufficient data reported. Based on this review, authors concluded that there is no sufficient economic evidence on which recommendations regarding screening for OAG can be based.

    According to review authors, future studies for economic models and clinical trials – and using the most recent technologies – may help policymakers to identify the most cost-effective screening methods.

    Methodology: The following databases were searched for relevant articles written in English: MEDLINE (1966-November Week 3 2005); EMBASE (1980-2005 Week 49); MEDLINE In Process & Non-indexed Citations (23rd February, 6th December 2005); Science Citation Index (SCI) (1981-3rd December 2005); NHS Economic Evaluation Database (NEED) (November 2005); Health Technology Assessment Database (HTA Database) (November 2005); Health Management Information Consortium (HMIC) (November 2005). Authors performed general searches within reviews.

    The following studies were included: studies performed in adult populations – including any intervention for OAG screening – and comparing both costs and outcomes.

    Studies that did not relate cost to outcome data, methodological papers, papers which reviewed economic evaluations, discursive analysis of costs/benefits, partial evaluation studies such as cost analyses, efficacy, or effectiveness evaluations and cost of treatment/burden of illness papers were excluded.

    Critical appraisal and data extraction were, according to the Centre for Reviews and Dissemination, for the critical appraisal of economic evaluations guidelines. Data was extracted by one reviewer and checked by a second reviewer. The two main areas of data extraction were the results of the economic evaluations (estimates of costs and effects) and the methods used to derive the results and their interpretation. Extracted data was summarised but no quantitative analysis was conducted.

    Applicability/external validity: Authors state that the outcome of this study is not relevant for policymakers as it suffers from many limitations. Authors note that none of the studies implicitly stated why the chosen strategies were appropriate settings, making it hard to judge if these are relevant strategies for other settings. In addition, authors state that different country reimbursement strategies and costs could complicate the interpretation of results, as they may not be applicable to other countries owing to differences in their economies or the way health services are organised (e.g. UK-based study from a US perspective).

    Geographic focus: Studies included were from the USA, UK and Canada.

     

    Summary of quality assessment: This review was based on relevant database searches. However, reference lists were not searched for additional articles and experts were not consulted. Furthermore, there was a language restriction as only English articles were looked at. Therefore, we could not be confident that relevant literature was not omitted.

    In addition, it is unclear whether two researchers independently participated in the screening. Data was extracted by one reviewer only. Overall, based on the information provided in the review, low confidence was attributed in the conclusions about the effects of this study.

    Publication source: Hernández R, Rabindranath K, Fraser C, Vale L, Blanco AA, Burr JM; OAG Screening Project Group. Screening for open angle glaucoma: systematic review of cost-effectiveness studies. J Glaucoma. 2008 Apr-May;17(3):159-68. Source
    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.